Clinical Trial

Bundle Branch Pacing to Preserve Ejection Fraction in Atrial Fibrillation Trial

Study acronym: BEAT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn whether left bundle branch area pacing, a technique designed to activate the heart's natural electrical conduction system, is better than conventional right ventricular pacing in adults with permanent atrial fibrillation, preserved heart pumping function, and a need for a pacemaker. The main questions it aims to answer are: Does left bundle branch area pacing reduce the risk of death, unplanned hospitalization for heart failure, or the need to replace the initial pacing system with biventricular pacing over 2 years? Does it better preserve heart function and quality of life, without increasing pacemaker-related complications? Researchers will compare left bundle branch area pacing with conventional right ventricular pacing. A total of 642 participants will be randomly assigned to receive one of these two pacing strategies. Participants will: Have a single-chamber pacemaker implanted using either left bundle branch area pacing or conventional right ventricular pacing Undergo electrocardiograms, echocardiograms, and pacemaker checks during 2 years of follow-up Attend follow-up visits approximately 2, 12, and 24 months after implantation Be contacted by telephone approximately 6 and 18 months after implantation Complete questionnaires about their health and quality of life at the beginning and end of the study
Trial Details
NCT Number NCT07759700
Lead Sponsor Poitiers University Hospital
Collaborators: University Hospital, Grenoble, Nouvelles Cliniques Nantaises, Nantes, Centre Hospitalier Universitaire de Besancon, Centre Hospitalier de PAU, Centre Cardiologique du Nord, St Denis, Centre Hospitalier Universitaire de Saint Etienne, LA ROCHE SUR YON HOSPITAL, Centre Hospitalier Régional d'Orléans, University Hospital, Tours
Conditions Permanent Atrial Fibrillation, Preserved Ejection Fraction
Enrollment 642 participants
Start Date 2026-09-15
Primary Completion 2028-08-14 (estimated)
Study Completion 2030-08-14 (estimated)
Updated on ClinicalTrials.gov 2026-08-12